MAP
HALO icon

Moody Aldrich Partners’s Halozyme HALO Stock Holding History

Moody Aldrich Partners’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-96,737
Closed -$6.17M – 188
2025
Q1 		$6.17M Sell
96,737
-10,878
-10% -$632K 1.29% 19
2024
Q4 		$5.15M Sell
107,615
-2,943
-3% -$151K 0.95% 33
2024
Q3 		$6.33M Sell
110,558
-24,954
-18% -$1.43M 1.15% 29
2024
Q2 		$7.1M Buy
135,512
+11,588
+9% +$508K 1.38% 10
2024
Q1 		$5.04M Buy
+123,924
New +$4.65M 0.86% 46

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Moody Aldrich Partners's HALO Position: Q2 2025 in Review

Moody Aldrich Partners sold out of Halozyme (HALO) in Q2 2025, closing a stake of 96,737 shares — an estimated $6.17M sold.

Moody Aldrich Partners first reported a position in HALO in Q1 2024 and held it in 5 quarters. The position peaked at $7.1M in Q2 2024. 551 funds tracked by Wall St. Rank hold HALO as of Q2 2025.

  • Moody Aldrich Partners reported no remaining Halozyme position as of Q2 2025 after selling out during the quarter.
  • Moody Aldrich Partners sold 96,737 Halozyme shares in Q2 2025, an estimated $6.17M.
  • Moody Aldrich Partners first reported a position in Halozyme in Q1 2024 and held it in 5 quarters.
  • Moody Aldrich Partners's Halozyme position peaked at $7.1M in Q2 2024.
  • 551 funds tracked by Wall St. Rank held Halozyme as of Q2 2025.

Based on Moody Aldrich Partners's 13F filing for Q2 2025, filed 4 Aug 2025.